GCM
DXCM icon

Grisanti Capital Management’s DexCom DXCM Stock Holding History

Grisanti Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-203,800
Closed -$3.78M – 72
2018
Q1 		$3.78M Buy
+203,800
New +$3.01M 1.73% 25

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Grisanti Capital Management's DXCM Position: Q2 2018 in Review

Grisanti Capital Management sold out of DexCom (DXCM) in Q2 2018, closing a stake of 203,800 shares — an estimated $3.78M sold.

Grisanti Capital Management first reported a position in DXCM in Q1 2018 and held it in 1 quarter. The position peaked at $3.78M in Q1 2018. 289 funds tracked by Wall St. Rank hold DXCM as of Q2 2018.

  • Grisanti Capital Management reported no remaining DexCom position as of Q2 2018 after selling out during the quarter.
  • Grisanti Capital Management sold 203,800 DexCom shares in Q2 2018, an estimated $3.78M.
  • Grisanti Capital Management first reported a position in DexCom in Q1 2018 and held it in 1 quarter.
  • Grisanti Capital Management's DexCom position peaked at $3.78M in Q1 2018.
  • 289 funds tracked by Wall St. Rank held DexCom as of Q2 2018.

Based on Grisanti Capital Management's 13F filing for Q2 2018, filed 3 Aug 2018.